Kleiner Perkins breaks its rules with Corixa

Immunex Corp. co-founder Steven Gillis is turning his immunology skills to vaccine development. Gillis has joined Corixa Corp., a Seattle-based Kleiner Perkins Caufield & Byers startup that today was to announce the completion of a first venture round of $15 million.

Other investors are Enterprise Partners, Interwest Partners, Olympic Venture Partners and Forward Ventures...